[Skip to Navigation]
Sign In
May 15, 2013

Pelvic Organ Prolapse Surgery: Long-term Outcomes and Implications for Shared Decision Making

Author Affiliations

Author Affiliation: Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center, Departments of Obstetrics and Gynecology and Urology, Georgetown University School of Medicine, Washington, DC.

JAMA. 2013;309(19):2045-2046. doi:10.1001/jama.2013.5528

Pelvic floor disorders, including pelvic organ prolapse, urinary incontinence, fecal incontinence, and other sensory disorders of the gastrointestinal and genitourinary tract, are common with nearly 1 in 4 US women having at least 1 pelvic floor condition.1 In this issue of JAMA, Nygaard and colleagues2 present findings from the extended Colpopexy and Urinary Reduction Efforts (extended CARE) trial. The original CARE trial3 was a double-blind randomized trial of 322 women mostly with advanced (stage 3-4) prolapse and without stress incontinence symptoms undergoing an open abdominal synthetic mesh sacrocolpopexy procedure either with or without a urethropexy for prevention of stress urinary incontinence.

Add or change institution